Skip to content

Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate?

Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03385434
Acronym
Endorings-2
Enrollment
292
Registered
2017-12-28
Start date
2018-02-01
Completion date
2022-02-01
Last updated
2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Adenoma, Colonic Neoplasms, Colonic Polyp, Colonoscopy

Keywords

Colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy

Brief summary

Screening colonoscopy for colorectal cancer is essential to diagnose and remove adenomas, precancerous stages of colorectal cancer. Unfortunately approximately 25 % of all adenomas are missed during the examination. Recently a new colonoscopy accessory, the Endorings-2 (EndoAid Ltd., Casearea, Israel), has been designed to improved the detection of adenomas during colonoscopy (adenoma detection rate). Endorings-2 is a silicone-rubber device that is fitted on the colonoscope and is equipped with circular flexible silicon rings mechanically stretching the colonic folds during withdrawal. This study aims to evaluate the efficacy of Endorings-2 to improve the adenoma detection rate in a prospective, blinded clinical trial. 292 patients with an indication for a screening colonoscopy shall be included (1:1 randomization in standard colonoscopy versus Endorings-2-assisted colonoscopy).

Interventions

DEVICEEndorings-2

292 patients with an indication for screening colonoscopy will be included. 146 patients will receive a standard colonoscopy and 146 patients will receive an Endorings-2 assisted colonoscopy (1:1 standard colonoscopy vs Endorings-2-assisted colonoscopy).

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with an indication for a screening colonoscopy.

Exclusion criteria

* Patients under 18 years, pregnancy * Patients with prior colectomy or partial colectomy * Patients with a history of colorectal cancer * Patients with hereditary polyposis syndromes (FAP, HNPCC) * Patients with a stricture of the colon * Patients receiving anticoagulation prohibiting a colonoscopy * inability to have a patient education * bad conditions prohibiting a colonoscopy

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the adenoma detection rate during screening colonoscopyIntraoperative. Adenomas detected directly during the examination.The primary outcome of this study is the adenoma detection rate of the standard colonoscopy in comparison to the Endorings-assisted colonoscopy.

Countries

Germany

Contacts

Primary ContactFrank Lenze, MD
frank.lenze@uni-muenster.de+492518357935
Backup ContactArne Bokemeyer, MD
arne.bokemeyer@ukmuenster.de+492518357935

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026